Aimmune Therapeutics, Inc. Debt to Equity Ratio 2015-2020 | AIMT
Current and historical debt to equity ratio values for Aimmune Therapeutics, Inc. (AIMT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Aimmune Therapeutics, Inc. debt/equity for the three months ending June 30, 2020 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2020-06-30 | $0.19B | $0.18B | 1.03 |
| 2020-03-31 | $0.19B | $0.24B | 0.79 |
| 2019-12-31 | $0.10B | $0.10B | 0.97 |
| 2019-09-30 | $0.10B | $0.15B | 0.63 |
| 2019-06-30 | $0.09B | $0.21B | 0.46 |
| 2019-03-31 | $0.09B | $0.26B | 0.34 |
| 2018-12-31 | $0.04B | $0.30B | 0.14 |
| 2018-09-30 | $0.04B | $0.25B | 0.16 |
| 2018-06-30 | $0.04B | $0.29B | 0.14 |
| 2018-03-31 | $0.03B | $0.33B | 0.10 |
| 2017-12-31 | $0.03B | $0.18B | 0.16 |
| 2017-09-30 | $0.02B | $0.21B | 0.11 |
| 2017-06-30 | $0.02B | $0.24B | 0.08 |
| 2017-03-31 | $0.01B | $0.27B | 0.04 |
| 2016-12-31 | $0.01B | $0.29B | 0.05 |
| 2016-09-30 | $0.01B | $0.16B | 0.08 |
| 2016-06-30 | $0.01B | $0.18B | 0.04 |
| 2016-03-31 | $0.01B | $0.19B | 0.03 |
| 2015-12-31 | $0.01B | $0.21B | 0.03 |
| 2015-09-30 | $0.00B | $0.22B | 0.02 |
| 2015-06-30 | $0.00B | $0.06B | 0.07 |
| 2015-03-31 | $0.00B | 0.00 | |
| 2014-09-30 | $0.00B | 0.00 | |
| 2014-06-30 | $0.00B | 0.00 | |
